Table 3. Summary of patient data.
| Patient identity | Gender | Age (years) | Age at epilepsy onset (years) | Histopathological result | Antiepileptic drugs (pre-op) | Reconstructed SBs |
|---|---|---|---|---|---|---|
| Hu_1 | Female | 36 | 4 | GGL | LTG, LEV | 53 |
| Hu_2 | Female | 25 | 12 | AHS | LTG | 25 |
| Hu_3 | Female | 25 | 23 | GGL | Zebinix, LEV | 25 |
| Hu_4 | Male | 33 | 5 | Gliosis | LEV, CBZ | 25 |
| Hu_5 | Male | 63 | 24 | AHS | LEV, LTG, CBZ | 22 |
| Hu_6 | Male | 49 | 36 | AHS | Vimpat, ZNS | - |
AHS: Ammon's horn sclerosis; GGL: Ganglioglioma; LEV: Levetiracetam; LTG: Lamotrigine; ZNS: Zonisamide; CBZ: Carbamazepine.